• BioNTech CEO Ugur Sahin disclosed sales of ordinary shares on Oct. 8-9, 2026.
• Disposed of 63,209 shares at USD 92.3142 to USD 95.3733.
• Directly held ordinary shares fell to zero following the transactions.
• Continued to report 39,218,111 ordinary shares held indirectly.
• Trades were executed under a Rule 10b5-1 plan adopted on June 3, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000035), on October 09, 2026, and is solely responsible for the information contained therein.